Gracell Biotechnologies Inc. American Depositary Shares
GRCL
GRCL was delisted on the 21st of February, 2024.
63 hedge funds and large institutions have $552M invested in Gracell Biotechnologies Inc. American Depositary Shares in 2023 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 20 increasing their positions, 10 reducing their positions, and 8 closing their positions.
311% more capital invested
Capital invested by funds: $134M → $552M (+$418M)
238% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 8
150% more funds holding in top 10
Funds holding in top 10: 2 → 5 (+3)
100% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 10
40% more funds holding
Funds holding: 45 → 63 (+18)
64% less call options, than puts
Call options by funds: $216K | Put options by funds: $602K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
+$13.3M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
+$9.22M |
| 3 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$6.7M |
| 4 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$6.63M |
| 5 |
TAL
TIG Advisors LLC
New York
|
+$5.81M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$7.87M |
| 2 |
LGM
Logos Global Management
San Francisco,
California
|
-$7.27M |
| 3 |
VC
Vivo Capital
Palo Alto,
California
|
-$6.06M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$4.67M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$2.19M |
GRCL Hedge Fund Activity: Q4 2023 in Review
63 institutional investors reported a position in Gracell Biotechnologies Inc. American Depositary Shares (GRCL) for Q4 2023, worth a combined $552M — up 311% from $134M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new GRCL positions and 8 closed out — a net gain of 19 holders — while 20 added to existing stakes and 10 trimmed.
The largest buyer was Sio Capital Management, adding an estimated $13.3M. The largest seller was Hudson Bay Capital Management, cutting an estimated $7.87M.
- 63 institutional investors held Gracell Biotechnologies Inc. American Depositary Shares (GRCL) as of Q4 2023, up from 45 in Q3 2023.
- Funds reported $552M of Gracell Biotechnologies Inc. American Depositary Shares stock for Q4 2023, up 311% quarter-over-quarter.
- 27 funds opened new Gracell Biotechnologies Inc. American Depositary Shares positions in Q4 2023 and 8 closed out, a net change of +19 holders.
- The largest Gracell Biotechnologies Inc. American Depositary Shares buyer in Q4 2023 was Sio Capital Management, an estimated $13.3M added.
- The largest Gracell Biotechnologies Inc. American Depositary Shares seller in Q4 2023 was Hudson Bay Capital Management, an estimated $7.87M sold.
Based on aggregated 13F filings for Q4 2023.